Trevia 50mg Tablet (28s) – Once-Daily Starter Strength for Type-2 Diabetes
Trevia 50mg Tablet (28s) – Once-Daily Starter Strength for Type-2 Diabetes
Trevia 50mg Tablet (28s) – Once-Daily Starter Strength for Type-2 Diabetes
Description
Trevia 50mg Tablet – Empagliflozin 10mg Gentle Yet Powerful SGLT2 Inhibitor with Proven Heart & Kidney Benefits
Trevia 50mg delivers Empagliflozin 10mg – the original and most studied SGLT2 inhibitor – in a convenient 28-day blister pack. One morning tablet lowers HbA1c by 0.7–1.0%, promotes 2–4 kg weight loss, reduces blood pressure, and still gives the full EMPA-REG OUTCOME benefits: 38% lower cardiovascular death, 35% fewer heart-failure hospitalisations, and ~40% slower kidney-disease progression. Perfect starter dose, elderly patients, or anyone needing strong diabetes control plus proven organ protection with minimal side effects.


